- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
Comic Relief and GSK team up to help fight malaria
15 December 2015 • Author: Victoria White
A new fund – created through a £17m donation from GSK and £5m from Comic Relief – will provide targeted grants over the next five years to organisations on the frontline, tackling malaria and improving health in five malaria endemic countries in sub-Saharan Africa and Asia. These grants, made and managed by Comic Relief, will complement current malaria programmes and help build sustainable ways to ensure people can access diagnosis and prevention at the right time and in the right place.
The partnership aims to support the World Health Organization’s target to cut malaria case incidence and mortality rates by 90% over the next 15 years and the Roll Back Malaria partnership’s goal of a malaria-free world. The WHO strategy focuses on bolstering global and national programmes to control malaria and increase access to diagnosis, prevention and treatment.
Partnership aims to reduce the burden of malaria by 90% by 2030
Significant progress has been made since 2000. Deaths have more than halved through increased use of bed nets, scale-up of diagnostic testing and better access to medicines. But the disease continues to take a heavy human and economic toll, straining already fragile health systems. In 2015 alone, there were an estimated 214 million new malaria cases and 438,000 deaths – 90% of which were in Africa.
Ramil Burden, Vice-President for Africa and Developing Countries at GSK, said: “As a healthcare company, GSK has long been involved in battling this disease but we know more needs to be done; we are delighted to partner with Comic Relief, who bring a deep understanding of supporting communities to improve health and prospects. Our partnership will support global efforts aimed at trying to reduce the burden of malaria by 90% by 2030. Not only will this help unlock human and economic potential, but it will also provide a springboard for managing other current and future health challenges.”
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd B&W Tek Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited Butterworth Laboratories Ltd CAPSUGEL NV Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) Eurofins BioPharma Product Testing EUROGENTEC F.P.S. Food and Pharma Systems Srl GE Analytical Instruments IDBS JEOL Europe Kaiser Optical Systems Inc. L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited Lonza MA Business Metrohm Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Ocean Optics Panasonic Biomedical Sales Europe B.V. Peak Scientific ReAgent Russell Finex Limited Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Viavi Solutions, Inc Watson-Marlow Fluid Technology Group Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Yusen Logistics